Saba Capital Keeps Buying Ellsworth Growth & Income Shares, Betting on a Market Rebound amid Low Prices and Convertible‑Focused Strategy

Saba Capital’s Buying Frenzy: What It Means for Ellsworth Growth & Income

Saba Capital Management, L.P. has been on an aggressive buying run at Ellsworth Growth & Income over the past month. The latest transaction on 21 October involved a purchase of 2,600 shares at $11.58 per share, bringing Saba’s indirect holdings to roughly 1.79 million shares. This comes after a series of purchases in the preceding weeks—most notably 56,083 shares on 14 October and 17,079 shares on 19 October—indicating a sustained commitment to the fund. The timing is noteworthy: the fund’s share price was hovering near its 52‑week low ($18.41) and had slipped 3.7 % monthly, yet Saba continues to accumulate, suggesting a belief that the shares are undervalued or that a strategic event is forthcoming.

Implications for Investors and the Fund’s Outlook

From an investor’s standpoint, Saba’s continued buying spree could be a double‑edged sword. On one hand, the fund’s price‑to‑earnings ratio of 4.95—well below the industry average for closed‑ended equity funds—paired with Saba’s confidence, may signal a buying opportunity for value seekers. On the other hand, the fund’s underlying strategy of investing primarily in convertible securities and the fact that it is managed by Gabelli Funds, a specialist in such instruments, means that the fund’s performance is tightly coupled to interest rate movements and the broader equity market. If the market continues to lag, Saba’s purchases might be seen as a bet on a market rebound rather than a fundamental shift in the fund’s asset quality.

The lack of any announced governance changes or new management appointments in the filing keeps the narrative ambiguous. However, Saba’s stake—now representing a significant portion of the fund’s shares—could afford it influence over proxy votes and potentially shape the fund’s strategic direction, especially if it aligns with other large shareholders.

Profiling Saba Capital Management, L.P.

Saba Capital is a quantitative investment manager that routinely trades in mid‑cap, high‑growth equities. Over the last six months, its activity at Ellsworth has been largely buy‑heavy, with a few sell transactions in February that totaled over 70,000 shares. The February sells appear to have been a portfolio rebalancing move, as the prices were above the October averages, suggesting a tactical exit from positions that had appreciated. In contrast, the October buying spree shows a cumulative purchase of over 150,000 shares at a price range of $11.39–$12.03—well below the fund’s current market price. This pattern aligns with Saba’s historical strategy of identifying undervalued securities in the secondary market and positioning for long‑term gains.

Historically, Saba’s trades have been executed through funds it manages, providing a layer of anonymity that can keep other market participants off balance. The fact that Saba’s trades are reported under a “funds and/or accounts for which Saba serves as investment manager” clause indicates that the purchases are part of a larger portfolio strategy rather than a standalone bet on Ellsworth.

What Investors Should Watch

• Share Price Dynamics: The fund has been trading close to its 52‑week low. A rebound could validate Saba’s thesis, but sustained weakness might erode confidence.
• Proxy Voting Power: With a sizable stake, Saba could influence voting outcomes on key fund matters, potentially steering management toward more growth‑focused strategies.
• Market Conditions: As a convertible‑focused fund, interest rate fluctuations will materially affect valuations. An uptick in rates could depress convertible values, impacting the fund’s NAV and, consequently, Saba’s holdings.
• Future Disclosure: Any subsequent filings that reveal additional purchases or changes in Saba’s stake will provide clearer signals about the investment manager’s long‑term view.

In sum, Saba Capital’s recent buying activity at Ellsworth Growth & Income reflects a bullish stance in a market that remains volatile. For investors, the key takeaway is that a significant institutional player believes the shares are undervalued—an assertion that warrants close monitoring of both the fund’s performance metrics and broader market trends.